Differences between Human Plasma and Serum Metabolite Profiles

Background Human plasma and serum are widely used matrices in clinical and biological studies. However, different collecting procedures and the coagulation cascade influence concentrations of both proteins and metabolites in these matrices. The effects on metabolite concentration profiles have not been fully characterized. Methodology/Principal Findings We analyzed the concentrations of 163 metabolites in plasma and serum samples collected simultaneously from 377 fasting individuals. To ensure data quality, 41 metabolites with low measurement stability were excluded from further analysis. In addition, plasma and corresponding serum samples from 83 individuals were re-measured in the same plates and mean correlation coefficients (r) of all metabolites between the duplicates were 0.83 and 0.80 in plasma and serum, respectively, indicating significantly better stability of plasma compared to serum (p = 0.01). Metabolite profiles from plasma and serum were clearly distinct with 104 metabolites showing significantly higher concentrations in serum. In particular, 9 metabolites showed relative concentration differences larger than 20%. Despite differences in absolute concentration between the two matrices, for most metabolites the overall correlation was high (mean r = 0.81±0.10), which reflects a proportional change in concentration. Furthermore, when two groups of individuals with different phenotypes were compared with each other using both matrices, more metabolites with significantly different concentrations could be identified in serum than in plasma. For example, when 51 type 2 diabetes (T2D) patients were compared with 326 non-T2D individuals, 15 more significantly different metabolites were found in serum, in addition to the 25 common to both matrices. Conclusions/Significance Our study shows that reproducibility was good in both plasma and serum, and better in plasma. Furthermore, as long as the same blood preparation procedure is used, either matrix should generate similar results in clinical and biological studies. The higher metabolite concentrations in serum, however, make it possible to provide more sensitive results in biomarker detection.

[1]  Jerzy Adamski,et al.  Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics , 2011, Metabolomics.

[2]  Christian Gieger,et al.  Metabolic Profiling Reveals Distinct Variations Linked to Nicotine Consumption in Humans — First Results from the KORA Study , 2008, PloS one.

[3]  Tobin J Dickerson,et al.  Characterization of differences between blood sample matrices in untargeted metabolomics. , 2011, Analytical chemistry.

[4]  B. McManus,et al.  The Human Serum Metabolome , 2011, PloS one.

[5]  F. Mannello Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[6]  R. Taguchi,et al.  Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways* , 2002, The Journal of Biological Chemistry.

[7]  C. Gieger,et al.  SLC2A9 influences uric acid concentrations with pronounced sex-specific effects , 2008, Nature Genetics.

[8]  R. Weinshilboum,et al.  Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.

[9]  Christian Gieger,et al.  Genetics Meets Metabolomics: A Genome-Wide Association Study of Metabolite Profiles in Human Serum , 2008, PLoS genetics.

[10]  Elaine Holmes,et al.  Impact of analytical bias in metabonomic studies of human blood serum and plasma. , 2006, Analytical chemistry.

[11]  Christian Gieger,et al.  A genome-wide perspective of genetic variation in human metabolism , 2010, Nature Genetics.

[12]  E. Fukusaki,et al.  Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. , 2010, Journal of bioscience and bioengineering.

[13]  R Holle,et al.  KORA - A Research Platform for Population Based Health Research , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[14]  J. Ladenson,et al.  Serum versus heparinized plasma for eighteen common chemistry tests: is serum the appropriate specimen? , 1974, American journal of clinical pathology.

[15]  C. Gieger,et al.  Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. , 2010, Blood.

[16]  J. Tissot,et al.  Plasma/serum proteomics: pre-analytical issues , 2007, Expert review of proteomics.

[17]  Christian Gieger,et al.  Meta-Analysis of 28,141 Individuals Identifies Common Variants within Five New Loci That Influence Uric Acid Concentrations , 2009, PLoS genetics.

[18]  R. Nijveldt,et al.  Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. , 2002, Analytical biochemistry.

[19]  Inka J. Appel,et al.  Comparison of serum versus plasma collection in gas chromatography – Mass spectrometry‐based metabolomics , 2010, Electrophoresis.

[20]  Å. Lernmark,et al.  Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus , 2002, Diabetes Care.

[21]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[22]  F. Kronenberg,et al.  Influence of hematocrit on the measurement of lipoproteins demonstrated by the example of lipoprotein(a). , 1998, Kidney international.

[23]  A. Jaffe,et al.  It's time for a change to a troponin standard. , 2000, Circulation.

[24]  Y. Igarashi,et al.  Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. , 1997, Journal of biochemistry.

[25]  Guangju Zhai,et al.  Serum branched-chain amino acid to histidine ratio: a novel metabolomic biomarker of knee osteoarthritis , 2010, Annals of the rheumatic diseases.

[26]  Ying Zhang,et al.  Differences in metabolite profile between blood plasma and serum. , 2010, Analytical biochemistry.